Tue. Jun 25th, 2024
Adaptive Biotechnologies Announces Business Update Conference Call and Webcast Scheduled for April 2, 2024

In the world of biotechnology, Adaptive Biotechnologies Corporation stands out as a company that is dedicated to revolutionizing disease diagnosis and treatment through the harnessing of the power of the adaptive immune system. The company’s immune medicine platform enables the decoding of the genetics of the adaptive immune system with scale, precision, and speed.

Adaptive Biotechnologies believes that the adaptive immune system is a powerful tool for diagnosing and treating most diseases but has not been fully utilized due to challenges in decoding it. The company collaborates with biopharmaceutical companies, informs drug development, and develops clinical diagnostics in two main areas: Minimal Residual Disease (MRD) and Immune Medicine. Their products and pipeline aid in diagnosing, monitoring, and treating diseases such as cancer, autoimmune disorders, and infectious diseases with the goal of developing personalized immune-driven clinical products for each patient.

Investors who have questions can reach out to Karina Calzadilla, Vice President of Investor Relations at investors@adaptivebiotech.com. For media inquiries, contact Erica Jones, Associate Director of Corporate Communications at media@adaptivebiotech.com.

On Tuesday, April 2nd 2024 at 1:30 p.m Pacific Time / 4:30 p.m Eastern Time Adaptive Biotechnologies will be hosting a business update conference call and webcast after the market closes. The live audio of this webcast will be available on the “Investors” section of their website at www.adaptivebiotech.com. It will also be archived for replay within 24 hours after its completion for those who were unable to watch it live

By Aiden Nguyen

As a content writer at newscholarly.com, I delve into the realms of storytelling with the power of words. With a knack for research and a passion for crafting compelling narratives, I strive to bring forth engaging and informative articles for our readers. From decoding complex concepts to unraveling current events, I aim to captivate and educate through the art of writing. Join me on this journey as we explore the ever-evolving landscape of news and knowledge together.

Leave a Reply